Showing 161-170 of 334 grants

Title Institution Researcher Program Duration Total Award Amount
Effects of Volagidemab on Glucagon Rescue from Insulin-Induced Hypoglycemia REMD Biotherapeutics Dung Thai Improving Lives 30-June-2023 to 29-June-2026 $672,000.00
Determining how frequent infections alter autoreactive T-cell fates and type 1 diabetes risk Regents of the University of Minnesota Zachary Shaheen Cures 01-June-2024 to 31-May-2025 $199,890.00
Employing PD-L1-Modified Biomaterials to Induce Islet Allograft Tolerance Following Perihepatic Transplantation in Nonhuman Primates Regents of the University of Minnesota Melanie Graham Cures 01-April-2025 to 31-March-2027 $918,744.88
Preclinical development of a combinatorial therapy with a humanized antibody to serpinB13 in type 1 diabetes Regents of the University of Minnesota Jan Czyzyk Cures 01-June-2022 to 31-May-2025 $765,000.00
Growing Beta Cell Replacement in T1D by Tolerizing Stem Cell-Derived Islets Regents of the University of Minnesota Bernhard Hering Cures 01-August-2025 to 31-July-2027 $688,430.02
Hybrid Closed Loop Therapy for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study (CLVerEX) Regents of the University of Minnesota Antoinette Moran Cures 01-April-2023 to 31-March-2026 $1,739,442.00
Mechanistic Etiologies Underlying the Impact of Verapamil to Preserve β Cell Function in Type 1 diabetes Regents of the University of Minnesota Antoinette Moran Cures 01-September-2024 to 31-August-2026 $643,946.00
JDRF and M-Diabetes Center of Excellence at the University of Michigan Regents of the University of Michigan Thomas Gardner Cures 01-October-2019 to 30-September-2025 $7,795,943.05
Repurposing LRRK2 inhibitors for β cell protection in T1D Regents of the University of Michigan Scott Soleimanpour Cures 01-September-2023 to 31-August-2026 $750,000.00
Eye biorepository: A hub for the restoring vision moonshot Regents of the University of Michigan Patrice Fort Improving Lives 01-March-2025 to 28-February-2026 $218,095.83